GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 125 filers reported holding GOSSAMER BIO INC in Q4 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $77,683 | +24.5% | 64,736 | +30.7% | 0.00% | – |
Q1 2023 | $62,410 | -50.4% | 49,532 | -13.3% | 0.00% | – |
Q4 2022 | $125,823 | -59.1% | 57,112 | +122.5% | 0.00% | – |
Q3 2022 | $307,551 | +38.6% | 25,672 | -3.1% | 0.00% | – |
Q2 2022 | $221,847 | -5.7% | 26,505 | -2.2% | 0.00% | – |
Q1 2022 | $235,237 | -37.8% | 27,101 | -18.9% | 0.00% | – |
Q4 2021 | $378,000 | -14.1% | 33,426 | -4.6% | 0.00% | – |
Q3 2021 | $440,000 | +41.5% | 35,030 | -8.5% | 0.00% | – |
Q2 2021 | $311,000 | -4.9% | 38,294 | +8.3% | 0.00% | – |
Q1 2021 | $327,000 | -4.4% | 35,370 | +0.0% | 0.00% | – |
Q4 2020 | $342,000 | -14.7% | 35,360 | +9.3% | 0.00% | – |
Q3 2020 | $401,000 | +5.0% | 32,337 | +6.8% | 0.00% | – |
Q2 2020 | $382,000 | +32.2% | 30,282 | +6.5% | 0.00% | – |
Q1 2020 | $289,000 | -30.4% | 28,442 | +7.2% | 0.00% | – |
Q4 2019 | $415,000 | -9.2% | 26,536 | -0.1% | 0.00% | -100.0% |
Q3 2019 | $457,000 | +65.6% | 26,574 | +113.5% | 0.00% | – |
Q2 2019 | $276,000 | – | 12,449 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 8,055,916 | $6,708,967 | 4.36% |
Velan Capital Investment Management LP | 3,065,136 | $2,552,645 | 2.06% |
Monashee Investment Management LLC | 5,304,212 | $4,417,348 | 1.84% |
CVI Holdings, LLC | 976,108 | $812,903 | 1.61% |
Samsara BioCapital, LLC | 6,130,268 | $5,105,287 | 1.56% |
SILVERARC CAPITAL MANAGEMENT, LLC | 6,130,268 | $5,105,287 | 1.55% |
Opaleye Management Inc. | 4,754,200 | $3,959,298 | 1.29% |
Octagon Capital Advisors LP | 8,187,883 | $6,818,869 | 1.05% |
NEA Management Company, LLC | 15,727,942 | $13,098,230 | 1.01% |
GREAT POINT PARTNERS LLC | 6,230,272 | $5,188,571 | 0.94% |